Profile
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS diseases with TERP (Target-Engineered Responsive Polymer) technology, a non-viral delivery platform enabling safe, repeat intravenous delivery of RNA and biologics to the brain.
Website
qurcan.comContact
-
Mohammad Ali Amini, President and Chief Executive OfficerTel: +1 647-447-7449Email: ma.amini@qurcan.com
-
-
-
-
-
Event details
Name: Ontario at BioJapan 2026
Date: October 7 - 9, 2026
Event contact
Stephen Ip
Senior International Market Consultant
Japan and Korea
Tel: +1 437-339-1529
Email: stephen.ip@ontario.ca
Participants
13 in total
-
Founded in 2002, Amptek Technologies has been providing turnkey engineering design services since its inception.… -
BioBox builds the infrastructure that turns scientific judgment and reasoning into reproducible, scalable AI… -
The Center for Research on Environmental Microbiology (CREM Co Labs) is an Ontario-based research… -
The Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest, is a unique… -
Genvira Biosciences is a preclinical oncology company developing viral vector-based therapies for cancers with… -
GRTHealth provides modular remote monitoring solutions to maximize the ability of seniors to live… -
i-RNA Corporation is a Canadian preclinical biotech developing small interfering… -
PurMinds NeuroPharma is a Canadian life-science company supporting the commercialization of point-of-care testing… -
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS…
-
RAN BioLinks Canada Ltd is a Canadian technology company headquartered in Toronto, that builds software for… -
Singularity Pharma is a drug discovery company developing novel drugs to treat CNS disorders with… -
Sussex Research Laboratories Inc. (Ottawa, Canada) is a globally recognized specialist in empowering therapeutic… -
Transpharmation is a company specializing in translational pharmacology that collaborates with pharmaceutical…